Business UpdateMay 27, 2026, 04:07 PM
Aktis Oncology CEO to Present at Jefferies Healthcare Conference
AI Summary
Aktis Oncology, Inc. announced that its President and Chief Executive Officer, Matthew Roden, Ph.D., will present at the Jefferies Global Healthcare Conference. The presentation is scheduled for Wednesday, June 3, 2026, at 4:20 p.m. ET, and will be accessible via a live webcast on the company's investor relations website. An archived replay will be available for approximately 90 days following the event. The company will likely discuss its miniprotein radioconjugate platform and clinical-stage pipeline programs, AKY-1189 and AKY-2519.
Key Highlights
- Aktis Oncology CEO to present at Jefferies Global Healthcare Conference.
- Presentation scheduled for June 3, 2026, at 4:20 p.m. ET.
- Live webcast available via Aktis Oncology's investor website.
- Replay will be available for approximately 90 days.
- Company advancing AKY-1189 and AKY-2519 clinical programs.
- Aktis has a discovery collaboration with Eli Lilly and Company.
Price Impact
More from AKTS